Rheumatoid Arthritis And Shingles.
The newest medications old to scrutinize autoimmune diseases such as rheumatoid arthritis don't appear to raise the risk of developing shingles, experimental research indicates. There has been concern that these medications, called anti-tumor necrosis factor (anti-TNF) drugs, might prolong the chances of a shingles infection (also known as herpes zoster) because they create by suppressing a part of the immune system that causes the autoimmune attack. "These are commonly in use drugs for people with rheumatoid arthritis and other autoimmune diseases, and the issue was whether or not they increased the risk of shingles.
We found there is no increased hazard when using these drugs, which was reassuring," said study author Dr Kevin Winthrop, friend professor of infectious disease and public health and preventive medicine at Oregon Health and Science University in Portland. Results of the contemplate are published in the March 6 issue of the Journal of the American Medical Association.
Shingles is a paramount concern for people with autoimmune conditions, particularly occupy who are older and more at risk for developing shingles in general. Shingles is caused when the same virus that causes chickenpox is reactivated. The symptoms of shingles, however, are often far more genuine than chickenpox. It typically starts with a ardent or tingling pain, which is followed by the appearance of fluid-filled blisters, according to the US National Institutes of Neurological Disorders and Stroke.
Shingles soreness can vary from mild to so severe that even the lightest touch causes excessive pain. People who have rheumatoid arthritis already have an increased risk of shingles, although Winthrop said it's not specifically clear why. It may be due to older age, or it may have something to do with the disease itself. Rheumatoid arthritis and other autoimmune conditions are treated with many unlike medications that help dampen the immune set and, hopefully, the autoimmune attack.
Showing posts with label rheumatoid. Show all posts
Showing posts with label rheumatoid. Show all posts
Wednesday 8 January 2020
Wednesday 20 November 2019
Women Suffer From Rheumatoid Arthritis More Often Than Men
Women Suffer From Rheumatoid Arthritis More Often Than Men.
Rheumatoid arthritis patients can on the whole look out on forward to a much better quality of life today than they did 20 years ago, renewed research suggests. The observation is based on a comparative multi-year tracking of more than 1100 rheumatoid arthritis patients. All had been diagnosed with the often permanently debilitating autoimmune ailment at some point between 1990 and 2011. The reason for the brighter outlook: a combination of better drugs, better performance and mental health therapies, and a greater effort by clinicians to boost patient spirits while encouraging continued somatic activity.
And "Nowadays, besides research on new drug treatments, digging is mainly focused on examining which treatment works best for which patient, so therapy can become more 'tailor-made' and therefore be more effective for the separate patient," said Cecile Overman, the study's lead author. Overman, a doctoral undergraduate in clinical and health psychology at Utrecht University in the Netherlands, expects that in another 20 years, rheumatoid arthritis patients will have the same grandeur of life as anyone else "if the focus on the whole patient - not just the disease, but also the person's lunatic and physical well-being - is maintained and treatment opportunities continue to evolve. The enquiry was released online Dec 3, 2013 in Arthritis Care and Research.
In rheumatoid arthritis, the body's safe system mistakenly attacks the joints, the Arthritis Foundation explains. The resulting redness can damage joints and organs such as the heart. Patients endure sudden flare-ups with warm, swollen joints, pain and fatigue. Currently there is no cure but a classification of drugs can treat symptoms and prevent the condition from getting worse.
Up to 1 percent of the world's residents currently struggles with the condition, according to the World Health Organization. The current study was composed first of all of female rheumatoid arthritis patients (68 percent). Women are more prone to developing the working order than men. Patients ranged in age from 17 to 86, and all were Dutch.
Each was monitored for the sally of disease-related physical and mental health disabilities for anywhere from three to five years following their first diagnosis. Disease activity was also tracked to assess progression. The observed trend: a theatric two-decade drop in physical disabilities. The researchers also saw a decline in the incidence of appetite and depression.
Rheumatoid arthritis patients can on the whole look out on forward to a much better quality of life today than they did 20 years ago, renewed research suggests. The observation is based on a comparative multi-year tracking of more than 1100 rheumatoid arthritis patients. All had been diagnosed with the often permanently debilitating autoimmune ailment at some point between 1990 and 2011. The reason for the brighter outlook: a combination of better drugs, better performance and mental health therapies, and a greater effort by clinicians to boost patient spirits while encouraging continued somatic activity.
And "Nowadays, besides research on new drug treatments, digging is mainly focused on examining which treatment works best for which patient, so therapy can become more 'tailor-made' and therefore be more effective for the separate patient," said Cecile Overman, the study's lead author. Overman, a doctoral undergraduate in clinical and health psychology at Utrecht University in the Netherlands, expects that in another 20 years, rheumatoid arthritis patients will have the same grandeur of life as anyone else "if the focus on the whole patient - not just the disease, but also the person's lunatic and physical well-being - is maintained and treatment opportunities continue to evolve. The enquiry was released online Dec 3, 2013 in Arthritis Care and Research.
In rheumatoid arthritis, the body's safe system mistakenly attacks the joints, the Arthritis Foundation explains. The resulting redness can damage joints and organs such as the heart. Patients endure sudden flare-ups with warm, swollen joints, pain and fatigue. Currently there is no cure but a classification of drugs can treat symptoms and prevent the condition from getting worse.
Up to 1 percent of the world's residents currently struggles with the condition, according to the World Health Organization. The current study was composed first of all of female rheumatoid arthritis patients (68 percent). Women are more prone to developing the working order than men. Patients ranged in age from 17 to 86, and all were Dutch.
Each was monitored for the sally of disease-related physical and mental health disabilities for anywhere from three to five years following their first diagnosis. Disease activity was also tracked to assess progression. The observed trend: a theatric two-decade drop in physical disabilities. The researchers also saw a decline in the incidence of appetite and depression.
Saturday 13 January 2018
New Researches In Treatment Of Rheumatoid Arthritis
New Researches In Treatment Of Rheumatoid Arthritis.
About half of rheumatoid arthritis patients stopped taking their medications within two years after they started them, a unripe office finds June 2013. Rheumatoid arthritis affects about one in 100 family worldwide and can cause radical joint destruction, deformity, pain and stiffness. The disease can reduce actual function, quality of life and life expectancy. The main reason about one-third of patients discontinued their medications was because the drugs mislaid their effectiveness, the study authors found. Other reasons included refuge concerns (20 percent), doctor preference (nearly 28 percent), resigned preference (about 18 percent) and access to treatment (9 percent), according to the bookwork results, which were presented Thursday at the annual meeting of the European League Against Rheumatism (EULAR), in Madrid, Spain.
Rheumatoid arthritis "is a growing disease, which, if left untreated, can significantly and interminably reduce joint function, patient mobility and quality of life," study lead framer Dr Vibeke Strand, a clinical professor at Stanford University School of Medicine, said in an EULAR newsflash release. "Studies have shown that patients sustain maximum benefit from rheumatoid arthritis therapy in the first two years - yet our data highlight significant discontinuation rates during this moment period".
About half of rheumatoid arthritis patients stopped taking their medications within two years after they started them, a unripe office finds June 2013. Rheumatoid arthritis affects about one in 100 family worldwide and can cause radical joint destruction, deformity, pain and stiffness. The disease can reduce actual function, quality of life and life expectancy. The main reason about one-third of patients discontinued their medications was because the drugs mislaid their effectiveness, the study authors found. Other reasons included refuge concerns (20 percent), doctor preference (nearly 28 percent), resigned preference (about 18 percent) and access to treatment (9 percent), according to the bookwork results, which were presented Thursday at the annual meeting of the European League Against Rheumatism (EULAR), in Madrid, Spain.
Rheumatoid arthritis "is a growing disease, which, if left untreated, can significantly and interminably reduce joint function, patient mobility and quality of life," study lead framer Dr Vibeke Strand, a clinical professor at Stanford University School of Medicine, said in an EULAR newsflash release. "Studies have shown that patients sustain maximum benefit from rheumatoid arthritis therapy in the first two years - yet our data highlight significant discontinuation rates during this moment period".
Subscribe to:
Posts (Atom)